End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.08 CNY | +1.91% | -10.06% | -4.58% |
Apr. 30 | Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises | RE |
Apr. 26 | Cabio Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 535M 74M | Sales 2025 * | 680M 94.1M | Capitalization | 2.82B 390M |
---|---|---|---|---|---|
Net income 2024 * | 117M 16.19M | Net income 2025 * | 149M 20.62M | EV / Sales 2024 * | 5.27 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
24.1
x | P/E ratio 2025 * |
18.8
x | Employees | 444 |
Yield 2024 * |
1.61% | Yield 2025 * |
0.92% | Free-Float | 49.98% |
1 day | -1.41% | ||
1 week | -11.74% | ||
Current month | -14.71% | ||
1 month | +35.60% | ||
3 months | +42.15% | ||
6 months | -14.49% | ||
Current year | -6.37% |
Managers | Title | Age | Since |
---|---|---|---|
De Wei Yi
CEO | Chief Executive Officer | 59 | 04-09-21 |
Hua Biao Wang
DFI | Director of Finance/CFO | 59 | 04-09-21 |
Zhi Ming Wang
CTO | Chief Tech/Sci/R&D Officer | 55 | 04-09-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Ming Yao
CHM | Chairman | 61 | 15-12-14 |
De Wei Yi
CEO | Chief Executive Officer | 59 | 04-09-21 |
Qi Liu
BRD | Director/Board Member | 47 | 21-12-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 17.08 | +1.91% | 7 277 188 |
24-05-16 | 16.76 | -1.41% | 7,696,562 |
24-05-15 | 17 | +0.35% | 6,501,455 |
24-05-14 | 16.94 | -2.64% | 9,236,328 |
24-05-13 | 17.4 | -2.90% | 9,981,141 |
End-of-day quote Shanghai S.E., May 15, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.37% | 391M | |
+17.39% | 8.48B | |
+6.26% | 7.6B | |
+7.55% | 6.39B | |
-5.30% | 3.75B | |
-7.57% | 3.71B | |
-1.78% | 1.36B | |
-27.39% | 1.11B | |
+18.29% | 1.02B | |
-9.48% | 924M |
- Stock Market
- Equities
- 688089 Stock